Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.67 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.67 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.52 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | DCLRE1B | Q9H816 | 1/20 | 0.46 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.46 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.46 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Biphenyl SCHEMBL25183774 | 1.00 | TAAR1 (0.67) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL29451178 | 1.00 | TAAR1 (0.67) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL27652491 | 0.97 | TAAR1 (0.64) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL15605009 | 0.97 | TAAR1 (0.71) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL30704326 | 0.97 | TAAR1 (0.64) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| Hydrochloric Acid SCHEMBL28562931 | 0.95 | TAAR1 (0.61) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| Hydrochloric Acid SCHEMBL9014594 | 0.95 | TAAR1 (0.61) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL28871408 | 0.95 | TAAR1 (0.61) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL28102063 | 0.95 | TAAR1 (0.61) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 | |
| SCHEMBL28562929 | 0.93 | TAAR1 (0.59) | TAAR1ESR2CYP17A1CYP3A4CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 499 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240339730-A1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-10-10 | — | — | US | claimed |
| CN-118724768-A | N-alkyl substituted nitrogen-containing compound and preparation method thereof | 武汉光化学技术研究院 | 2024-10-01 | — | — | CN | claimed |
| EP-4411963-A2 | ELECTROCHEMICAL DEVICE | Ningde Amperex Technology Ltd. (CN) | 2024-08-07 | — | — | EP | claimed |
| US-12057602-B2 | Electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2024-08-06 | — | — | US | claimed |
| EP-3966880-B1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LTD (CN) | 2024-07-31 | — | — | EP | claimed |
| CN-114987024-B | Composite board mobile phone cover with textures and production process thereof | 惠州市纵胜电子材料有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116715689-A | Synthesis method of flurbiprofen and intermediate thereof | 珠海市海瑞德生物科技有限公司 | 2023-09-08 | — | — | CN | claimed |
| US-20230198096-A1 | ELECTROCHEMICAL DEVICE | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-06-22 | — | — | US | claimed |
| US-11637319-B2 | Electrolytic solution and electrochemical device | NINGDE AMPEREX TECHNOLOGY LIMITED (CN) | 2023-04-25 | — | — | US | claimed |
| CN-111454150-B | Synthesis method of (S) -2-aryl propionate compound | 南京工业大学 | 2023-03-28 | — | — | CN | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| EP-0991793-B1 | METHOD FOR PREPARING 2-ARYL OR 2-HETEROCYCLYL CHIRAL PROPIONIC ACIDS AND THEIR ESTERS | CT NAT DE BR LA RECH SCIENT (FR) | 2001-12-05 | — | — | EP | claimed |
| US-6294069-B1 | MIXTURE OF PROPIONIC ACID DERIVATIVE IS ELECTROCHEMICALLY REDUCED IN THE PRESENCE OF NICKEL COMPLEX CATALYST AND SUPPORTING ELECTROLYTE IN ELECTROLYSIS CELL PROVIDED WITH ELECTRODES, PRODUCT IS HYDROLYZED OR TRANSESTERIFIED | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2001-09-25 | — | — | US | claimed |
| EP-0809618-A1 | PROCESS FOR PREPARING OLEFINS | ALBEMARLE CORPORATION (US) | 1997-12-03 | — | — | EP | claimed |
| WO-1996025376-A1 | PROCESS FOR PREPARING OLEFINS | ALBEMARLE CORPORATION (US) | 1996-08-22 | — | — | WO | claimed |
| CN-1061415-A | The title complex that contains S (+)-phenyl alkane acids and aminosaccharide | PUETTER MEDICE CHEM PHARM (DE) | 1992-05-27 | — | — | CN | claimed |
| CN-1061405-A | The title complex that contains S (+)-phenyl alkane acids and Alpha-hydroxy paraffinic acid | PUETTER MEDICE CHEM PHARM (DE) | 1992-05-27 | — | — | CN | claimed |
| CN-1061404-A | The mixture that contains S (+) phenyl alkane acids and a-amino acid | PUETTER MEDICE CHEM PHARM (DE) | 1992-05-27 | — | — | CN | claimed |
| CN-1050373-A | Preparation optically-active 2-aryl-alkanoic, the particularly method of 2-arylpropionic acid | PUETTER MEDICE CHEM PHARM (DE) | 1991-04-03 | — | — | CN | claimed |
| EP-0227078-A1 | Process for preparing (S)-alpha-methylarylacetic acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1987-07-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | TAAR1 77/4885ESR2 1314/4885CYP17A1 230/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.